Yat Sun Or insider trades

Open-market stock purchases and sales by Yat Sun Or, Chief Scientific Officer at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Dec 5, 2013.

Recent trades

DateStockTradeValue
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$48.6K
Dec 5, 2025ENTA Enanta Pharmaceuticals IncSold$34K
Dec 1, 2025ENTA Enanta Pharmaceuticals IncSold (not open market)$10.6K
Nov 25, 2025ENTA Enanta Pharmaceuticals IncBought (not open market)—

Companies traded

  • ENTA Enanta Pharmaceuticals Inc: 35 sales, last Feb 12, 2026

Get free alerts when Yat Sun Or files a new trade →